The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Czechia proposes changes that will better define the role of patient organisations when informing patients about therapeutic procedures without violating advertising regulations.

Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a leading healthcare company in Korea, announced the ...

Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would ... responsible for the scientific evaluation, supervision and safety monitoring of medicines.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare ...

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer ... EMA is a decentralised agency of the EU, responsible for the scientific evaluation, supervision and ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.